Navigation Links
Quintiles to Open Clinical Research Office in Wilmington, NC
Date:1/17/2008

Growth driving second new office opening in North Carolina in last 12

months

RESEARCH TRIANGLE PARK, N.C., Jan. 17 /PRNewswire/ -- Quintiles Transnational Corp. today announced that the global leader in pharmaceutical services will open an office in Wilmington, N.C. The new office is an expansion of Quintiles' clinical research in pharmaceutical and biotechnology development.

The new Wilmington office is Quintiles' second expansion within the state in the last 12 months. Last January, Quintiles opened a data processing center in Williamston, N.C.

"With a strong educational system and a positive environment for business, North Carolina is clearly the leading location for global clinical research organizations," said Mike Mortimer, Executive Vice President and Chief Administrative Officer. "We were founded in the Research Triangle more than 25 years ago, and we've fueled our growth by tapping into an excellent work force like that in North Carolina, with people committed to improving health care around the world. Our employees find Quintiles to be a place for fulfilling, rewarding work and in return they are driving the company to great success."

The Wilmington office is centrally located in the North State Bank Building, 1411 Commonwealth Drive, convenient to major thoroughfares and the Wilmington airport, and not far from Wrightsville Beach. Quintiles will occupy two of the three stories of the bank building.

Founded in 1982 by current CEO and Chairman Dennis Gillings, CBE, the company is considered a pioneer in clinical research. Quintiles is the largest provider of pharmaceutical services in the world, with more than 19,000 employees in more than 50 countries. More than 1,500 are employed in North Carolina.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at http://www.quintiles.com.


'/>"/>
SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
2. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
3. Expert Cardiologist Joins Quintiles Medical Group
4. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
5. YM BioSciences provides update on AeroLEF(TM) clinical development program
6. Irving Dark Named Vice President of Cytel Clinical Research Services
7. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
8. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
9. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
10. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
11. Association of Clinical Research Organizations (ACRO) Elects New Officers for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  Caris Life Sciences, ... Lustgarten Foundation, the largest private funder of pancreatic ... trial evaluating the impact of immunotherapy in the ... trial enrollment services to identify potential trial candidates ... between treating physicians and study investigators. The Lustgarten ...
(Date:1/18/2017)...  Market Research Future published a half-cooked research report on Global ... at a CAGR of 12% during the period 2016 to 2022. ... ... cell division without any control. These abnormal cells have the ability ... cells can spread to other parts of the body through the ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... Balance™ GT soybeans. The new Balance™ GT Soybean Performance System will combine industry-leading ... isoxaflutole, the active ingredient in the new Balance® Bean herbicide. The Balance™ GT ...
(Date:1/17/2017)... 17, 2017  An international team of researchers ... St. Boniface Hospital Albrechtsen Research Centre/University of Manitoba ... unmet health need affecting nearly one in 15 ... Investigation, their results identify small molecule drugs with ... neuronal injury in animal models of metabolic, chemical ...
Breaking Biology Technology:
(Date:1/18/2017)... MedNet Solutions , an innovative ... spectrum of clinical research, is proud to announce ... the organization in terms of corporate growth, outside ... and services. The company,s exceptional achievements can be ... iMedNet ™ – MedNet,s ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Forecasts, 2015 - 2022," projects that the global biometric technology market is expected to ... 2016 to 2022. Continue Reading ... ...      ...
(Date:1/6/2017)... 5, 2017  SomaLogic announced today that it ... established by iCarbonX, the China ... "Global Digital Health Ecosystem that can define each ... individual,s biological, behavioral and psychological data, the Internet ... companies, SomaLogic will provide proteomics data and applications ...
Breaking Biology News(10 mins):